BIO-TECHNE Corp - COMMON STOCK (TECH) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
TECH on Nasdaq
Shares outstanding
152,309,909
Price per share
$67.63
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
171,321,440
Total reported value
$10,072,444,984
% of total 13F portfolios
0.01%
Share change
+10,996,289
Value change
+$662,689,200
Number of holders
571
Price from insider filings
$67.63
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BIO-TECHNE Corp - COMMON STOCK (TECH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7% $566,544,556 11,011,556 BlackRock, Inc. 30 Jun 2025
PRICE T ROWE ASSOCIATES INC /MD/ 2.2% -57% $186,406,005 -$305,816,579 3,350,818 -62% T. Rowe Price Associates, Inc. 30 Sep 2025

As of 31 Dec 2025, 571 institutional investors reported holding 171,321,440 shares of BIO-TECHNE Corp - COMMON STOCK (TECH). This represents 112% of the company’s total 152,309,909 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BIO-TECHNE Corp - COMMON STOCK (TECH) together control 70% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 17,810,878 -0.68% 0.02% $1,047,457,735
BlackRock, Inc. 8% 12,129,125 +2% 0.01% $713,313,819
MORGAN STANLEY 5.5% 8,345,414 +15% 0.03% $490,794,044
STATE STREET CORP 3.8% 5,812,032 +1% 0.01% $341,805,602
WELLINGTON MANAGEMENT GROUP LLP 3.8% 5,734,049 +12% 0.06% $337,219,422
GEODE CAPITAL MANAGEMENT, LLC 3.2% 4,929,801 +0.05% 0.02% $289,502,286
PRICE T ROWE ASSOCIATES INC /MD/ 2.7% 4,075,194 +22% 0.03% $239,663,000
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.6% 4,012,818 +164% 0.08% $235,993,825
MAVERICK CAPITAL LTD 2.5% 3,850,923 +28% 2.4% $226,472,782
Invesco Ltd. 2.4% 3,678,659 -6.8% 0.03% $216,341,937
NEUBERGER BERMAN GROUP LLC 2.1% 3,129,334 -5.4% 0.14% $184,036,113
Select Equity Group, L.P. 1.9% 2,837,142 +26% 0.77% $166,852,321
AMERIPRISE FINANCIAL INC 1.8% 2,798,437 -0.59% 0.04% $164,576,211
MAIRS & POWER INC 1.8% 2,767,539 -1.4% 1.6% $162,758,957
DF DENT & CO INC 1.7% 2,592,215 -6.8% 2.2% $152,448,149
MACKENZIE FINANCIAL CORP 1.6% 2,414,165 -5.7% 0.17% $142,444,643
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 1.6% 2,398,265 +40% 0.39% $141,041,965
Sumitomo Mitsui Trust Group, Inc. 1.6% 2,368,162 +0.53% 0.08% $139,271,607
ALLIANCEBERNSTEIN L.P. 1.6% 2,364,845 +158% 0.04% $139,076,534
UBS Group AG 1.5% 2,224,263 +47% 0.03% $130,808,907
RGM Capital, LLC 1.4% 2,152,052 -6.4% 6.1% $126,562,178
Durable Capital Partners LP 1.4% 2,088,891 +50% 1.2% $122,847,680
AMERICAN CENTURY COMPANIES INC 1.3% 1,928,485 -5.4% 0.06% $113,414,203
SNYDER CAPITAL MANAGEMENT L P 1.3% 1,926,866 +12% 2.1% $113,318,989
DIMENSIONAL FUND ADVISORS LP 1.2% 1,794,293 +4.9% 0.02% $105,523,778

Institutional Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 171,321,440 $10,072,444,984 +$662,689,200 $58.81 571
2025 Q3 158,850,861 $8,835,899,945 +$43,569,058 $55.63 569
2025 Q2 158,628,992 $8,162,083,726 -$121,661,613 $51.45 549
2025 Q1 160,482,754 $9,405,648,682 +$179,026,718 $58.63 570
2024 Q4 156,683,809 $11,287,230,171 +$66,773,071 $72.03 570
2024 Q3 154,600,456 $12,351,604,330 +$7,433,196 $79.93 556
2024 Q2 155,869,664 $11,167,617,679 -$177,733,977 $71.65 567
2024 Q1 158,523,717 $11,156,213,905 +$202,103,671 $70.39 546
2023 Q4 155,453,274 $11,990,770,023 +$252,157,462 $77.16 525
2023 Q3 152,193,816 $10,358,362,931 +$40,449,398 $68.07 522
2023 Q2 151,139,522 $12,331,718,195 +$212,796,041 $81.63 521
2023 Q1 148,715,946 $11,031,044,107 -$125,004,989 $74.19 542
2022 Q4 150,382,048 $12,465,020,754 +$9,251,047,940 $82.88 536
2022 Q3 38,142,242 $10,837,756,102 +$194,266,932 $284.00 520
2022 Q2 37,209,172 $12,897,621,890 -$179,595,754 $346.64 534
2022 Q1 37,711,486 $16,331,488,594 +$324,651,170 $433.04 546
2021 Q4 36,855,059 $19,055,177,448 -$21,586,911 $517.34 560
2021 Q3 36,736,696 $17,797,604,388 +$72,229,932 $484.57 556
2021 Q2 36,589,162 $16,468,259,256 +$203,566,288 $450.26 504
2021 Q1 36,496,866 $13,940,028,921 +$172,769,577 $381.93 460
2020 Q4 36,189,306 $11,493,926,712 -$16,778,721 $317.55 426
2020 Q3 36,254,970 $8,982,485,029 -$42,929,390 $247.73 409
2020 Q2 36,379,136 $9,604,991,764 -$81,539,071 $264.07 384
2020 Q1 36,823,671 $6,987,799,245 +$119,012,127 $189.62 357
2019 Q4 35,776,726 $7,852,981,745 -$46,029,404 $219.51 366
2019 Q3 35,990,901 $7,043,547,397 +$117,132,644 $195.67 333
2019 Q2 35,416,061 $7,383,307,878 +$61,945,595 $208.49 362
2019 Q1 35,546,314 $7,057,725,860 +$61,379,403 $198.55 347
2018 Q4 35,371,213 $5,119,061,152 -$122,869,763 $144.72 316
2018 Q3 35,826,309 $7,311,255,210 +$15,680,998 $204.11 335
2018 Q2 35,998,975 $5,325,911,858 +$35,737,877 $147.95 333
2018 Q1 35,891,582 $5,420,812,522 -$28,478,791 $151.04 325
2017 Q4 36,357,570 $4,710,259,737 -$46,673,008 $129.55 288
2017 Q3 36,860,326 $4,455,237,647 -$52,528,460 $120.89 282
2017 Q2 37,300,606 $4,382,632,640 +$214,841,252 $117.50 272
2017 Q1 36,529,302 $3,713,044,239 +$392,401,939 $101.65 265
2016 Q4 35,943,908 $3,695,994,947 +$12,675,458 $102.83 270
2016 Q3 35,799,364 $3,917,777,202 -$132,633,733 $109.50 279
2016 Q2 37,060,472 $4,178,830,306 -$54,302,334 $112.77 278
2016 Q1 37,564,549 $3,550,310,945 +$20,269,808 $94.52 251
2015 Q4 37,359,133 $3,362,530,330 +$85,876,184 $90.00 258
2015 Q3 36,302,435 $3,356,422,402 -$28,590,696 $92.46 245
2015 Q2 36,725,188 $3,616,194,794 +$4,045,129 $98.47 238
2015 Q1 36,495,519 $3,659,215,883 +$67,728,039 $100.29 243
2014 Q4 36,050,484 $3,331,456,988 +$2,869,117,238 $92.40 252
2014 Q3 4,950,723 $463,140,000 +$463,140,000 $93.55 24